Response to Individualized vs. conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial

Fertil Steril. 2024 Apr;121(4):706. doi: 10.1016/j.fertnstert.2023.12.024. Epub 2023 Dec 24.

Authors

Salvatore Longobardi¹, Thomas M D'Hooghe²

Affiliations

¹ Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany.
² Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany; Department of Development and Regeneration, Laboratory of Endometrium, Endometriosis and Reproductive Medicine, KU Leuven, Leuven, Belgium; Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University Medical School, New Haven, Connecticut.

PMID: 38147958
DOI: 10.1016/j.fertnstert.2023.12.024

No abstract available

Publication types

Randomized Controlled Trial
Multicenter Study
Clinical Trial, Phase III
Letter

MeSH terms

Fertilization in Vitro*
Humans
Ovulation Induction*